Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...
The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.
Dechra, a global leader in veterinary specialty care, today announced the FDA approval of Zygolide ® (pergolide tablets), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback